Time to Treat: A System Redesign Focusing on Decreasing the Time from Suspicion of Lung Cancer to Diagnosis
Dorothy S. Lo, Robert A. Zeldin, Roland Skrastins et al. · Journal of Thoracic Oncology · 2007
Cited by 80 works. doi:10.1097/jto.0b013e318158d4b6
Authors
- Dorothy S. Lo
- Robert A. Zeldin
- Roland Skrastins
- Ian Fraser
- Harold F. Newman
- Alan A. Monavvari
- Yee Ung
- H. Joseph
- Teresa Downton
- Larissa Maxwell
- Jacinta M. Meharchand
References
- Cancer Statistics, 2006
- Prognostic Assessment of 2,361 Patients Who Underwent Pulmonary Resection for Non-small Cell Lung Cancer, Stage I, II, and IIIA
- The impact of delayed diagnosis of lung cancer on the stage at the time of operation
- Tackling excessive waiting times for elective surgery: a comparative analysis of policies in 12 OECD countries
- Improving surgical resection rate in lung cancer
- Surgical results and prognostic factors of pathologic N1 disease in non-small-cell carcinoma of the lung
- Costs and benefits of a one stop clinic compared with a dedicated breast clinic: randomised controlled trial * Commentary: one stop clinics should not be abandoned
- Impact of Revised Stage Classification of Lung Cancer on Survival
- Prognostic factors in clinical stage I non–small cell lung cancer
- The 1997 International Staging System for Non-Small Cell Lung Cancer